STEIIIFH Trademark

Trademark Overview


On Wednesday, August 24, 2016, a trademark application was filed for STEIIIFH with the United States Patent and Trademark Office. The USPTO has given the STEIIIFH trademark a serial number of 87149151. The federal status of this trademark filing is REGISTERED as of Tuesday, April 30, 2019. This trademark is owned by Kangstem Biotech CO., LTD.. The STEIIIFH trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, solutions for medical and clinical use for the treatment of cells; Biological preparations for the treatment of stem cells; Stem cells for medical purposes; Pharmaceutical preparations for the treatment of autoimmune disease; Cord blood for medical purposes; Bouillons for stem cell cultures; Pharmaceutical preparations for the treatment of stem cell mobilization; Pharmaceutical preparations for immunity adjustment; Allergy medications; Lotions for pharmaceutical purposes, namely, pharmaceutical skin lotions; Medicament formulating agents, namely, medicaments to help assist with the regeneration of ligament and tendon fibers; Chemico- pharmaceutical preparations for medical purposes, namely, pharmaceutical stem cell formulations for treatment of medical conditions; Chemico-pharmaceutical preparations for medical purposes, namely, pharmaceutical preparations for use in the treatment of bone marrow and stem cell transplantation; Pharmaceutical agents f...
steiiifh

General Information


Serial Number87149151
Word MarkSTEIIIFH
Filing DateWednesday, August 24, 2016
Status700 - REGISTERED
Status DateTuesday, April 30, 2019
Registration Number5740180
Registration DateTuesday, April 30, 2019
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, July 18, 2017

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical preparations, namely, solutions for medical and clinical use for the treatment of cells; Biological preparations for the treatment of stem cells; Stem cells for medical purposes; Pharmaceutical preparations for the treatment of autoimmune disease; Cord blood for medical purposes; Bouillons for stem cell cultures; Pharmaceutical preparations for the treatment of stem cell mobilization; Pharmaceutical preparations for immunity adjustment; Allergy medications; Lotions for pharmaceutical purposes, namely, pharmaceutical skin lotions; Medicament formulating agents, namely, medicaments to help assist with the regeneration of ligament and tendon fibers; Chemico- pharmaceutical preparations for medical purposes, namely, pharmaceutical stem cell formulations for treatment of medical conditions; Chemico-pharmaceutical preparations for medical purposes, namely, pharmaceutical preparations for use in the treatment of bone marrow and stem cell transplantation; Pharmaceutical agents for epidermis; Preparations of microorganisms for medical or veterinary use; Bacterial preparations for medical and veterinary use; Reagents for medical use; Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of diseases and disorders in the nature of stem cells for medical use; Dermatological pharmaceutical products; Pharmaceutical preparations for treating skin disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 30, 2016
Primary Code005
First Use Anywhere DateFriday, January 4, 2019
First Use In Commerce DateFriday, January 4, 2019

Trademark Owner History


Party NameKangstem Biotech CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSeoul 06302
KR

Party NameKangstem Biotech CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeoul 06302
KR

Party NameKangstem Biotech CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeoul
KR

Trademark Events


Event DateEvent Description
Tuesday, April 30, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, March 26, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, March 25, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sunday, March 24, 2019STATEMENT OF USE PROCESSING COMPLETE
Wednesday, March 6, 2019USE AMENDMENT FILED
Sunday, March 24, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 6, 2019TEAS STATEMENT OF USE RECEIVED
Friday, September 7, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 5, 2018EXTENSION 2 GRANTED
Wednesday, September 5, 2018EXTENSION 2 FILED
Wednesday, September 5, 2018TEAS EXTENSION RECEIVED
Friday, February 23, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 21, 2018EXTENSION 1 GRANTED
Wednesday, February 21, 2018EXTENSION 1 FILED
Wednesday, February 21, 2018TEAS EXTENSION RECEIVED
Friday, January 5, 2018ASSIGNED TO EXAMINER
Tuesday, September 12, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 18, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 18, 2017PUBLISHED FOR OPPOSITION
Wednesday, June 28, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 14, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, May 26, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 26, 2017EXAMINER'S AMENDMENT ENTERED
Friday, May 26, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, May 26, 2017EXAMINERS AMENDMENT E-MAILED
Friday, May 26, 2017EXAMINERS AMENDMENT -WRITTEN
Friday, May 12, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 12, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 4, 2017ASSIGNED TO LIE
Wednesday, April 19, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 9, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 9, 2016NON-FINAL ACTION E-MAILED
Friday, December 9, 2016NON-FINAL ACTION WRITTEN
Friday, December 2, 2016ASSIGNED TO EXAMINER
Tuesday, August 30, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, August 27, 2016NEW APPLICATION ENTERED IN TRAM